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Delayed  (cell-mediated)  hypersensitivity  reactions  have  been  regarded  by most 
workers as a qualitatively homogeneous group (1-3), although well-recognized  quanti- 
tative  differences  occur  depending  primarily  on  mode  of  immunization.  Classic 
tuberculin-type  delayed  hypersensitivity  is  typically produced  by  the  injection  of 
antigen in complete Freund's adjuvant or in other mixtures  containing products of 
the  tubercle  bacillus;  similar  reactivity  occurs  after  dermal  contact  with  simple 
chemicals and after infections  (mycobacterial, fungal, and viral).  Delayed-onset skin 
reactivity can also be produced transiently in a variety of soluble proteins by injection 
of antigen-antibody complexes or small amounts of the antigen intradermally without 
mycobacterial adjuvant (4, 5). The latter type of delayed hypersensitivity was termed 
"Jones-Mote" reactivity by Raffel and Newel (6), who considered it to be qualitatively 
different from classic  delayed hypersensitivity and resembling more closely reactions 
seen, by those investigators, in humans  (7). In the guinea pig, both types of delayed 
hypersensitivity give a maximum skin reaction at 24 hr, are not necessarily associated 
with circulating antibody, and can be passively transferred by cells but not by serum 
(5).  Jones-Mote reactivity occurs early in immunization and  is  evanescent,  waning 
with  the  appearance  of circulating  antibody,  in  contrast  to  classic  delayed hyper- 
sensitivity  which  persists  and  increases  with  time.  Histologic  studies  in  the  past 
(8-10)  have in general shown only quantitative  differences  between  classic  delayed 
and J ones-Mote hypersensitivity reactions, and most investigators have felt the latter 
to be a weak form of the delayed reaction. 
The  question  of  whether  the  two  types  of  delayed-onset  hypersensitivity 
involve  similar  or  qualitatively  different  mechanisms  was  studied  using  the 
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azobenzenearsonate  hapten  system.  Hapten-specific delayed hypersensitivity 
and/or hapten-specific antibody can be produced using different carriers, and 
so they seemed suitable for exploring the place of Jones-Mote hypersensitivity 
in the immune economy. We present here evidence in support of Raffel's con- 
tention that classic delayed hypersensitivity, produced by antigen incorporated 
in  complete  Freund's  adjuvant  (i.e.,  with  tubercle  bacilli),  and  Jones-Mote 
reactivity, the delayed-onset skin reactivity produced by antigen in incomplete 
Freund's  adjuvant  (i.e.,  without  tubercle  bacilli),  are  qualitatively distinct. 
Differences  between  the  reactions  have  emerged  with  respect  to  carrier  re- 
quirements for immunogenicity and for eliciting the skin test, extent of vascular 
permeability,  effect  of  anti-lymphocyte  serum  and  carrageenan  on  the  skin 
test,  the retest reaction,  and the histology of the lesion. A  preliminary paper 
has  been  published  elsewhere  (11).  The  histologic differences between  these 
reactions  are  fully  explored in  the  following paper  (12). 
Materials and Methods 
Azobenzenearsonate-N-acetyltyrosine (ABA-Tyr).--Was prepared as  described previously 
(iS). 
Azobenzenearsonate-Bovine Serum Albumin (ABA-BSA).--ArsaniYlC acid was  conjugated 
to bovine serum  albumin (purchased  from Pentex Biochemical, Kankakee, IlL) by reaction 
of 10  -5 moles of the diazotized acid per 10 mg of protein (70 ABA/BSA calculated molecular 
ratio). Preparation was as described previously (13). 
Preparation of Other Conjugates.--Bovine gamma globulin (BGG) obtained from  Pentex 
Biochemical, human insulin (Ins) from Eli Lilly & Co., Indianapolis, Ind., and human gamma 
globulin (HGG) from Pentex Biochemical were conjugated with arsanilic acid in the same way 
as that described for BSA. 
A polymer of D-glutamic acid, l)-alanine, and D-tyrosine (I)-GAT) was a gift of Dr. Thomas 
Gill, a polymer of the L-isomers (L-GAT)  was kindly provided by Dr. Paul Maurer; homo- 
polymers of L- and D-tyrosine were purchased from Pilot Labs. Conjugation was carried out in 
the manner described previously (13). 
lmmunizatlon.--White,  random-bred guinea pigs (400 g) were immunized by injection of a 
total of 0.1 ml of antigen emulsified in either complete Freund's adjuvant (CFA) or incomplete 
Freund's adjuvant (IFA) divided equally among the four footpads. IFA was made with 8.5 
parts fight mineral oil and 1.5 parts Arlacel  A; CFA contained 5 mg/ml of killed Mycobacteria 
in addition. 
Skin Testing.--Each group  of guinea pigs was skin tested at only one time interval, and 
reactions were examined at 4, 24, and 48 hr. Tests were intradermal, and the stated dose was 
injected in a total volume of 0.1 ml of saline. Animals manifesting  classic delayed hypersen- 
sitivity were most reactive at 3 wk, and this was the usual interval used. Animals immunized 
with IFA for Jones-Mote  reactivity were tested at 4,  7,  10,  14, or 21  days and generally 
showed good reactions at 7, 10, and 14 days; 4- and 21-day reactions were considerably less 
intense. Because later skin testing sometimes showed 4 hr erythema, presumably mediated by 
antibody (12), the 7 day interval was used routinely. In general, hapten-specific sensitivity  was 
elicited by heterologous  conjugates  of which ABA-L-GAT and ABA-BGG were particularly 
potent, and ABA-insulin slightly less so. Occasionally, as in the carrageenan and anti-lympho- 
cyte serum  studies,  the homologous immunizing  conjugate was used as skin test antigen to 
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Carrageenan Studies.--20 mg of carrageenan  (Marine  Colloids, Inc.,  Springfield, N.J.), 
10 mg/ml in saline, was injected intraperitoneally  2 hr prior to skin testing  in the animals 
noted. 
Anti-Lymphocyte Serum (A/_~') Studies.--The stated  dose of ALS was injected intraperi- 
toneally in test animals 4 hr prior to skin testing. The ALS was kindly supplied by Dr. John 
Burke, was produced in rabbits by injection of isolated guinea pig lymph node cells, and was 
absorbed with guinea pig red cells. 
Vascular Permeability Studies.--0.5 ml of 2.5% Evans blue in saline was injected  intra- 
cardiac in test animals with a 24 hr skin reaction. Blueing of the skin test site was evaluated 
over the subsequent 60 rain. 
Relest Reaclion.--This phenomenon was described by Arnason and Waksman (14). Animals 
receiving antigen in CFA were skin tested initially at 3 wk, then they were retested in the same 
and new sites 6 days later with doses identical with those used in initial skin tests. Similarly, 
groups of animals receiving antigen in IFA were retested  on the same and new sites 4 and 6 
days later with identical doses of skin test antigen as used initially. Evolution of reactions was 
observed at 2, 4, 6, 8, 24, and 48 hr. 
RESULTS 
Jones-Mote hypersensitivity is defined for the purposes of this study as the 
delayed-onset skin reaction produced in animals receiving antigen in incomplete 
Freund's  adjuvant  (IFA).  Like  classic  delayed  hypersensitivity,  it  becomes 
perceptible at about 6 hr and reaches its height at 18-24 hr. The reaction itself 
is  a  well-circumscribed  area  of  erythema,  appearing fainter  and considerably 
less  indurated  than  classic  delayed hypersensitivity,  and  is faded  or  gone at 
48 hr.  Classic delayed hypersensitivity is produced in this system by immuni- 
zation with  antigen  in complete Freund's adjuvant  (CFA). 
Antigenic Requirements for the Production  of 21B21-Specific Jones-Mote Reac- 
tivity.--Extensive experience  with  ABA conjugates in  CFA in  this laboratory 
has  revealed  that  ABA-tyr produces  excellent  hapten-specific  delayed hyper- 
sensitivity  but  no  detectable  antibody,  whereas  ABA-BSA  produces  poor 
hapten-specific  delayed  hypersensitivity  but  good  hapten-specific  antibody 
formation. Data in Table I  summarize this dichotomy. In animals immunized 
with  ABA-tyr in  CFA,  delayed  reactions  increased  progressively in  intensity 
for 21 days, at which time they were large and indurated.  No antibodies could 
be  demonstrated.  Animals  immunized  with  ABA-BSA in  CFA,  on  the  other 
hand,  developed  a  weaker,  rather  transient  delayed  reactivity  which  was 
maximal at 7 days and waning at 21 days, at which time both PCA and hemo- 
lytic antibody were demonstrable in most animals tested. 
If it is true that immunization in incomplete  Freund's adjuvant  simply pro- 
duces  milder  delayed  hypersensitivity,  one  would  expect  ABA-tyr to  be  an 
excellent  immunogen  for Jones-Mote  hypersensitivity.  That  such  is  not  the 
case is shown also in Table I. ABA-tyr in IFA produced little detectable delayed 
reactivity,  whereas  ABA-BSA in  IFA  produced  excellent  Jones-Mote  type 
reactions.  The  immunogenic  potency  of ABA-BSA for ABA-specific delayed 
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reactions produced by immunization  with  this material  in  CFA or IFA were 
indistinguishable  in  time  course  or  intensity.  The  results  of  these  immuno- 
genicity studies suggest that carrier requirements in this system for production 
of hapten-specific  Jones-Mote reactivity  more closely resemble  those for pro- 
duction of antibody than those for classic delayed hypersensitivity. 
TABLE I 
Immunogenicity  of ABA-tyr and ABA-BSA  in Complete and Incomplete Adjuvant 
Immunizing conjugate  Delayed skin  reactions to: 
50 t*g ABA-BGG 
ABA-tyr (100 t,g)  day 4  day 7  day 14  day 21 
in IFA  0*  (0/6):~  0  (0/6)  0  (0/5)  0  (0/6) 
in CFA  7  q-  (3/6)  10  -4-  (4/6)  16  ++  (6/6)  18  +++  (11/12) 
ABA-BSA (100 ~g) 
in IFA  3  --  (2/8)  12  4-  (9/10)  11  4-  (7/7)  5  --  (5/7) 
in CFA  7  --  (4/6)  14  +  (6/6)  9  4-  (5/6)  5  --  (4/8) 
50 t~g immunizing conjugate at day 7 
ABA-tyr (100 #g) 
in IFA  0(0/5) 
ABA-BSA (100 ~g) 
in IFA  16  q-  (6/6) 
Hapten-specific  AB formation at day 21 
ABA-tyr (100 tzg)  PCA antibody  Hemolytic antibody 
in CFA  0§  (0/20)  0  (0/20) 
ABA-BSA (100 t,g) 
in CFA  > 1:5  (10/19)  1:80  (18/19) 
* Skin reactions are recorded as average diameter of erythema in millimeters followed by 
the average degree of induration graded as follows: --, no induration;  -4-, minimal induration; 
+,  mild  induration;  ++,  moderate  induration;  +++,  marked  induration  with  central 
blanch. 
3~ Number of guinea pigs reacting:number tested. 
§ Average titer. 
Table II shows the results of skin tests with a variety of ABA conjugates 1 
wk after immunizing guinea pigs with 100/zg ABA-BSA in IFA. As in the case 
of delayed hypersensitivity,  the Jones-Mote type reactions  seen were hapten- 
specific in  that  they could be  elicited  with  approximately  equal  intensity  by 
ABA conjugates of carriers as diverse as insulin, human gamma globulin, poly- 
L-GAT, and poly-z-tyrosine. In contradistinction  to  antibody mediated  reac- 
tions, however, Jones-Mote reactions cotfld not be elicited by ABA conjugates 
of D-amino acid polymers, nor could animals be sensitized with such conjugates 
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Since early antibody in the guinea pig has been reported  to exhibit carrier 
specificity (15),  an attempt was made to see if L-tyrosine to which ABA was 
attached in the protein was necessary for full expression of Jones-Mote reac- 
tivity. An additional group of guinea pigs was immunized with ABA-BSA in 
TABLE  II 
Carrier Requirements for Eliciting A BA-Specific Jones-Mote  Skin Reactions  1 Wk after 
Immunization in Incomplete  Freund's  Adjuvant 
Skin reactions at 24 hr  to 50 #g of: 
Immunizing 
antigen  (100 #g) 
ABA- L-GAT  ABA-D-GAT  ABA-HGG 
ABA-BSA 
ABA-L-GAT 
ABA-D-GAT 
ABA-poly- 
L-tyr 
o ~  (5/6)* 
ABA-poly* 
I)-tyr 
0- (0/6)  12 +  (7/7) 
13 ~  (7/7) 
0-  (0/5) 
0 -  (0/7) 
0 -  (0/7) 
0 -  (0/5) 
ABA-ins 
s- (5/6)  lo -- (18/22) 
ABA-L-GA-D-T  ABA-D-T-getatin 
ABA-BSA  12 :~: (9/12)  9  --  (9/12)  8  --  (9/12) 
* See Table  for grading of skin reactions. 
TABLE III 
Effect of Carrageenan on Classic Delayed and Jones-Mote  Type Skin Reactions 
Type of reaction  Mode of immunization  Treatment  Skin reactions  at 24 hr to: 
O.T. 1: 500 
Delayed hypersensi- 
tivity 
Jones-Mote hyper- 
sensitivity 
Complete 
Freund's ad- 
juvant (0.25 mg 
Tbc) 
ABA-BSA 5 ~g in 
IFA 
Control group 
Carrageenan 20 
mg i.p. 
Control group 
Carrageenan 20 
mg i.p. 
11  ++  (8/8)* 
4-  (7/8) 
ABA-BSA (50 ~g) 
16-  (7/8) 
17  --  (10/10) 
* See Table I for grading of skin reactions. 
IFA, and at 1 wk skin was tested with ABA conjugates of a polymer containing 
l)-tyrosine, L-glutamic acid and L-alanine, and an ABA conjugate of D-tyrosine 
coupled to gelatin (both the generous gift of Dr. Michael Sela). As in the case of 
classic  delayed  hypersensitivity, both  materials  elicited  positive  reactions, 
indicating that the reaction was ABA specific and not dependent on the optical 
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Effect of Carrageenan  on the Skin Reaction.--Carrageenan,  a  polysaccharide 
from marine algae, has been shown to interfere with elicitation of classic delayed 
skin  reactions; interference with macrophage activity has been postulated  as 
its mechanism of action (16). Comparison of carrageenan effect in classic delayed 
and Jones-Mote type reactivity is given in Table III. Tuberculin hypersensi- 
tivity  is  markedly  diminished  in  intensity  in  carrageenan-treated  animals, 
while  identical  treatment  has  no  effect  on Jones-Mote  reactions  elicited  by 
ABA-BSA in guinea pigs immunized with ABA-BSA in IFA. 
Effect of Anti-Lymphocyte Serum on the Skin Reaction.--Table IV summarizes 
TABLE IV 
Effect of Anti-Lymphoctye Serum on Classic Ddayed and Jones-Mote Type Skin Reactions 
Type of reaction  Mode of immunization  Treatment  Skin reactions at 24 hr to: 
O.T. 1:500 
Delayed hypersensi- 
tivity 
Jones-Mote hyper- 
sensitivity 
Complete Freund's 
adjuvant (0.25 mg 
Tbc) 
ABA-BSA 100 ~g in 
IFA 
None 
ALS 2 ml 
ALS 1 ml 
None 
ALS 2 ml 
ALS 1 ml 
12  ++  (12/12)* 
0-  (0/5) 
5-  (3/4) 
ABA-L-GAT (50 ~g) 
10-  (11/12) 
0-  (0/5) 
0-  (0/6) 
* See Table I for grading of skin reactions. 
the  effect of ALS on delayed skin  reactions.  Animals receiving 2 ml of ALS 
appeared ill, while these receiving 1 ml showed no signs of systemic toxicity. 
Both Jones-Mote and classic  delayed hypersensitivity were almost completely 
inhibited by both doses of ALS. 
Vascular  Permeability  Studies.--Intravenous  injections  of Evans  blue  dye 
were made 24 hr after skin test with ABA-BSA in guinea pigs 1 wk after im- 
munization with ABA-BSA in IFA. The Jones-Mote skin reactions which were 
present  became pale blue  and  could be blanched with pressure,  indicating  a 
state  of hyperemia without dye extravasation;  no dye could be  seen  on the 
under surface of the skin. On the other hand, most classic delayed skin reactions 
in animals immunized with CFA showed extravasation of dye within 60 rain, 
confirming the reports of others  (17).  Injections of dye made within minutes 
after skin test also failed to show dye extravasation in animals immunized with 
IFA and  tested  at  1 wk as above. 
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reactivity  after  reinjection  of antigen  at  sites  of previous  delayed  reactions. 
We compared retest  responses  in classic delayed  and Jones-Mote  hypersensi- 
tivity, and the results  are given in Table V. Hapten-specific delayed reactions 
in  guinea  pigs  immunized  with  ABA-tyr in  CFA  evolved  in  the  usual  time 
course with  nothing grossly visible at 4  hr,  erythema without induration  at 8 
hr,  and maximal induration  and erythema at 24 hr.  When such a  site was re- 
tested  6  days later  a  delayed reaction with  a  much more rapid  evolution  oc- 
curred with maximal induration and erythema already present at 8 hr. A virgin 
TABLE V 
Comparison of Retest Reactions in Classic Delayed and Jones-Mote Ilypersensiti~ity 
Type of reaction 
Delayed hyper- 
sensitivity 
Jones-Mote 
hypersensi- 
tivity 
Skin reactions to 50 ~g ABA-HGG 
Immunization 
Initial 
ABA-tyr (2 
X  10  -6 
moles) in 
CFA 3 wk 
before 
testing 
ABA-BSA 
(100 ug) in 
IFA 1 wk 
before 
testing 
Time 
after 
skin 
testing I 
--i 
hr  I 
2  15 
4 
8 
24 
2 
4 
8 
24 
o  (o/10)$ 
o  (0/10) 
12-  (9/10) 
++  (lO/lO) 
0  (0/10) 
0  (0/10) 
8-  (9/10) 
9-  (7/9) 
Retest reaction*  .  Virgin site* 
o  (0/10)  0  (O/lO) 
10  +  (7/9)  er§  (8/9) 
14  ++  (9/9)  13  --  (9/9) 
14  +  (7/7)  16  +  (7/7) 
0  (o/to) 
er  (6/10) 
9-  (6/10) 
10-  (6/8) 
0  (0/10) 
er  (10/10) 
13  --  (10/10) 
14-  (8/8) 
* 6 days after initial test. 
See Table I for grading of skin reactions. 
§ er =  slight irregular erythema. 
site  tested  at  the  same  time  showed  the  original  time  course  with  maximal 
reactivity at  24 hr.  By contrast,  a  retest  of the site  of a  Jones-Mote reaction 
showed  little  difference  in  time  course  or  gross  appearance  from  the  initial 
test or another test done at the same time on a virgin site. 
DISCUSSION 
In the early 1930's Dienes and Mallory (18) compared immediate and delayed 
type skin reactions  and noted  that  delayed hypersensitivity could be induced 
to  protein  antigens  in  both  tuberculous  and  healthy  guinea  pigs,  although 
"quantitatively  distinctly  less  intense"  in  the  latter.  Delayed  reactivity  was 
noted  to be characterized  by marked  infiltration  with mononuclear cells.  The 
conclusion was that  tuberculin  type hypersensitivity is the usual  initial  stage 
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T. Duckett Jones and John R. Mote described in  1934 the development of skin 
reactivity in humans after repeated intradermal injections of small amounts of rabbit 
serum proteins  (7).  A 24 hr "tuberculin type" skin reaction eventually developed in 
the usual subject, followed after additional testing by an immediate wheal and flare 
reaction and waning of the delayed component. The immediate, but not the delayed 
component, was transferable by serum. The delayed reaction was defined as any 24 hr 
reaction having an erythema of more than  1 cm average diameter, with or without 
edema. 
Observations  in  rabbits  immunized with  human plasma  and  ovalbumin without 
Freund's adjuvant were reported in 1954 by Gell and Hinde (19), and they included 
the  description  of  a  delayed  component  to  the  Arthus  reaction  characterized  by 
mononuclear  cell  infiltration.  Passive  transfer  experiments  revealed  that  plasma 
recipients  demonstrated  minimal  mononuclear  infiltration,  while  cell  recipients 
showed  a  weak  immediate  skin  reaction  and  a  disproportionately  great  delayed 
mononuclear infiltration.  These authors  suggested that  "tuberculin  type reactions" 
could be considered as incomplete immunization procedures. 
In  1957,  Uhr,  Salvin,  and Pappenheimer  (4)  reported  the  induction of "delayed 
hypersensitivity"  in guinea pigs without adjuvants  by the intradermal  injection  of 
antigen-antibody complexes containing minute  amounts  of single  protein  antigens. 
Maximal  sensitization  developed  2-3  wk  before  detectable  circulating  antibody. 
Salvin  (5)  subsequently  demonstrated  similar  sensitivity  following  intradermal 
injection of ovalbumin in Freund's incomplete adjuvant. These authors assumed that 
the  observed  delayed  hypersensitivity  was  identical  with  classic  tuberculin  type 
hypersensitivity, and this assumption extended to later studies on desensitization (20) 
and systemic reactivity (21). 
Raffel and Newell  (6)  in  1958 challenged the assumption that classic  delayed re- 
activity is qualitatively identical with the delayed reactive state produced by antigen- 
antibody complexes or protein antigen without tubercle bacilli.  They pointed out the 
transient  nature  of the latter  reaction  and  its  apparent  relationship  to subsequent 
antibody production, and they suggested that it be distinguished from true delayed 
hypersensitivity as well as from hypersensitivity reactions of the immediate type. The 
term  "Jones-Mote type reactivity" was proposed for historical reasons. Nelson and 
Boyden  (22,  23)  differentiated  between  delayed reactions  to pure protein  antigens 
produced with or without Mycobacteria in adjuvant, and they agreed with Raffel and 
Newel on definition and terminology of the Jones-Mote reaction. Their studies, how- 
ever, did not exclude the possibility that Jones-Mote reactivity was simply a milder 
form of classic delayed hypersensitivity. 
Attempts to differentiate classic delayed hypersensitivity and Jones-Mote reactivity 
by histologic methods have in general revealed  only minor quantitative  differences 
(8-10). The Jones-Mote reaction was found to unfold at a slower rate without cellular 
invasion of epidermis or tissue necrosis, with relatively fewer lymphocytes, and with a 
greater proportion of mononuclear cells eventually giving rise to plasma cells. In recent 
reviews of delayed hypersensitivity both Uhr  (1) and Turk  (2) conclude that differ- 
ences noted between the Jones-Mote type and the tuberctflin type delayed hypersensi- 
tivity can be explained by quantitative considerations alone. 
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for  Jones-Mote  hypersensitivity  in  the  azobenzenearsonate  (ABA)  hapten 
system.  This  system,  which  gives  hapten-specific  delayed  hypersensitivity 
following  immunization  with  ABA-tyr  (24),  seemed particularly  well  suited 
for exploration  of the relationship  of Jones-Mote reactivity to  antibody-me- 
diated and cell-mediated hypersensitivity without detectable antibody forma- 
tion.  ABA-BSA  in  CFA,  on the other hand,  produces poor hapten-specific 
delayed hypersensitivity but good  ABA-specific antibody (25).  If Jones-Mote 
reactivity were  simply mild  delayed hypersensitivity,  then  ABA-tyr in IFA 
should  produce  good Jones-Mote lesions,  whereas  ABA-BSA in IFA  should 
produce little if any Jones-Mote reactivity. Our results proved otherwise,  lead- 
ing to the conclusion  that  immunogenicity  requirements  for  Jones-Mote  hy- 
persensitivity resemble those for antibody formation rather than for  true  de- 
layed hypersensitivity. 
Another possible explanation of the above findings  might be that antibody 
production "turns off" or conceals delayed skin reactivity, and that ABA-BSA 
is simply a better immunogen for both delayed hypersensitivity and antibody 
production.  Repeated  attempts  to  inhibit  expression  of delayed  hypersensi- 
tivity by antibody have been unsuccessful,  and in fact excellent delayed hyper- 
sensitivity in the presence of antibody occurs after concurrent  immunization 
with ABA-tyr and ABA-BSA. 1 This alternate explanation, then, appears to be 
untenable. 
Turk  and Heather  (26) have concluded from a histological  study of lymph 
nodes that Jones-Mote hypersensitivity is accompanied by lymph node changes 
typical  of  those  in  animals  developing  contact  sensitivity,  the  homograft 
reaction, or B.C.G. vaccination. These changes involve a high concentration of 
large pyroninophilic cells ("immunoblasts")  in paracortical areas 4 days after 
sensitization.  Hall (27) has found large  numbers of similar  cells in circulating 
lymph several days prior to the appearance of medullary plasma cells and anti- 
body formation, after immunization with many types of antigen. These mobile 
pyroninophilic  immunoblasts disseminate widely throughout  the body. What 
their  role  is in  delayed hypersensitivity remains  to be established,  but  it  is 
tempting to speculate that they are the antigen-recognizing  cells in the Jones- 
Mote reaction. 
The passive transfer of Jones-Mote reactivity has been achieved with sensi- 
tized lymphoid cells but not serum  (5),  and we have confirmed  these results. 
Our results with synthetic carrier polymers indicate that preformed antibody 
plays no role.  The D-polymer  carrier  of ABA,  while  capable of eliciting  skin 
reactions mediated  by preformed  antibody  (e.g.,  PCA  and  Arthus  reactions 
[13]), is unable to elicit the Jones-Mote skin reaction in sensitized  animals. That 
this is probably not due to carrier  specificity of some type of early antibody is 
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seen by the positive reactions to ABA conjugates of 9-tyrosine in L-amino acid 
carriers (Table I). As long as the carrier is immunogenic per se reactions are 
specific for the ABA group. 
The experiments using  anti-lymphocyte serum, while not conclusive, point 
to requirements for some type of lymphocyte population in Jones-Mote reac- 
tivity  as  in  classic  delayed  hypersensitivity. The  results  with  carrageenan, 
however, suggest that a macrophage population sensitive to its action does not 
make a significant contribution to Jones-Mote as contrasted with delayed hyper- 
sensitivity  reactions.  The  Evans  blue  dye  studies  indicate  the  Jones-Mote 
reaction to be a  simple vascular hyperemia rather than the result of increased 
vascular permeability. The significance of the absence of a  retest response in 
Jones-Mote skin sites cannot be evaluated since so little is known of the mech- 
anism of this phenomenon in delayed reaction sites. Nevertheless, it is another 
point of distinction between the two types of reaction. 
These results taken together suggest a mechanism for Jones-Mote reactions 
involving  an  active  stimulatory  cellular  response  requiring  an  immunogen 
acting  perhaps  on  the  circulating immunoblasts  released from lymph  nodes 
(28).  This  stimulation  may result in  differentiation into  antibody producing 
cells or, more probably, the release of mediators producing the unique cellular 
response involving the accumulation of basophils seen in this type of reaction 
(12). 
The  current  assumption  that  cell-mediated  delayed  hypersensitivity is  a 
qualitatively homogeneous response is surprising in view of the well-established 
heterogeneity of the antibody response. Understanding of classic cell-mediated 
tuberculin hypersensitivity has been facilitated by in vitro systems, showing 
that lymphocytes are antigen-responsive cells capable of elaborating substances 
which attract and activate macrophages (29). In the following paper (12)  we 
demonstrate a significantly different histologic pattern of cellular response for 
Jones-Mote reactions presumably involving a different mechanism. The major 
finding is the prominence of basophils in reactions elicited early after immuniza- 
tion with IFA. Since the reactions originally described by Jones and Mote (7) 
were operationally different and  of unknown histology, we propose that  the 
reactions studied  here and  in  the  subsequent paper  (12)  be designated  "cu- 
taneous  basophil  hypersensitivity." Several immune  responses  are  now  con- 
sidered  to  be  examples  of  classic  delayed  hypersensitivity;  these  include 
homograft rejection, tumor immunity, autoimmune disease,  and  contact der- 
matitis. Further clarification of the role played by basophil cellular responses 
in these  and  other immunologic phenomena is vital. 
S~ARY 
Jones-Mote reactivity, defined as a delayed-type skin reaction, occurs tran- 
siently early in  the course of immunization with protein antigens  or hapten 556  CUTANEOUS  BASOPHIL  HYPERSENSITIVITY. I. 
conjugates with  or  without  the  adjuvant  effect of tubercle  bacilli.  The  skin 
reaction is typically a flat, well-circumscribed erythema with little induration 
beginning at about 6 hr,  reaching a  peak at  18-24 hr,  and fading or gone at 
48 hr. 
Immunogenic  carrier  requirements  for  hapten-specific  Jones-Mote  hyper- 
sitivity resemble those of antibody production rather than of classic delayed 
hypersensitivity. Skin test antigen requirements indicate that the Jones-Mote 
reaction involves an active stimulatory response rather than combination with 
preformed  antibody,  since  ABA  conjugates  of  nonimmunogenic  B-polymers 
do not work.  Studies with ALS and carrageenan suggest that the lymphocyte 
is an important contributor to the reaction, but the macrophage is not. 
Because  the  reactions  studied  here  are  operationally different from  those 
described by Jones and Mote and because they have a characteristic histology, 
the term "cutaneous basophil hypersensitivity" is proposed. 
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